- Home
- ALEC vs NREF Comparison
ALEC vs NREF Comparison
Compare ALEC & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | NREF |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.8M | 298.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALEC | NREF |
|---|---|---|
| Price | $2.49 | $12.17 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $3.90 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 2.0M | 60.2K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $900.51 | N/A |
| Revenue Next Year | N/A | $4.05 |
| P/E Ratio | ★ $3.52 | $4.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $12.60 |
| 52 Week High | $2.84 | $18.43 |
Technical Indicators
Market Signals| Indicator | ALEC | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 61.48 | 24.86 |
| Support Level | $1.90 | N/A |
| Resistance Level | $2.65 | $16.04 |
| Average True Range (ATR) | 0.23 | 0.63 |
| MACD | 0.04 | -0.22 |
| Stochastic Oscillator | 64.22 | 2.51 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.